Can Fite Biopharma
CANF
#9682
Rank
NZ$21.66 M
Marketcap
$3.55
Share price
3.41%
Change (1 day)
7.83%
Change (1 year)

EPS for Can Fite Biopharma (CANF)

EPS in 2023 (TTM): -$4.59

According to Can Fite Biopharma 's latest financial reports the company's current EPS (TTM) is -$4.62. In 2022 the company made an earnings per share (EPS) of -$5.03 an increase over its 2021 EPS that were of -$15.08.

EPS history for Can Fite Biopharma from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.59-8.68%
2022-$5.03-66.67%
2021-$15.08-33.38%
2020-$22.64-64.07%
2019-$63.02-26.27%
2018-$85.48-10.53%
2017-$95.54-36.67%
2016-$150.8544.58%
2015-$104.34-40.15%
2014-$174.33-47.45%
2013-$331.73-77.14%
2012-$1,451127.17%
2011-$638.85